Anthra[1,9-cd]pyrazol-6(2H)-one

References

• Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
• B. D. Lee, J.-H. Shin, J. VanKampen, L. Petrucelli, A. B. West, H. S. Ko, Y. Lee, K. A. Maguire-Zeiss, W. J. Bowers, H. J. Federoff, V. L. Dawson, T. M. Dawson, Nat. Med. 2010, 16, 998.
• Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models (a review)
• T. Kramer, F. L. Monte, S. Göring, G. M. O. Amombo, B. Schmidt, ACS Chem. Neurosci. 2012, 3, 151.

References

• PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells
  • T.C. Ho, S.L. Chen, Y.C. Yang, C.L. Liao, H.C. Cheng, Y.P. Tsao, Cardiovasc. Res. 2007, 76, 213.
• Nongenotropic, anti-apoptotic signaling of 1α,25(OH)₂-vitamin D₃ and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes: MEDIATION BY Src, PHOSPHATIDYLINOSITOL 3-, AND JNK KINASES
  • A.M. Vertino, C.M. Bula, J.R. Chen, M. Almeida, L. Han, T. Bellido, S. Kousteni, A.W. Norman, S.C. Manolagas, J. Biol. Chem. 2005, 280, 14130.

References

• 1)SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
  • B. L. Bennett, D. T. Sasaki, B. W. Murray, E. C. O’Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, D. W. Anderson, Proc. Natl. Acad. Sci. USA 2001, 98, 13681.
• 2)Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
  • Y.-S. Heo, S.-K. Kim, C. I. Seo, Y. K. Kim, B.-J. Sung, H. S. Lee, J. I. Lee, S. Y. Park, J. H. Kim, K. Y. Hwang, Y.-L. Hyun, Y. H. Jeon, S. Ro, J. M. Cho, T. G. Lee, C.-H. Yang, EMBO J. 2004, 23, 2185.
• 3)A mammalian scaffold complex that selectively mediates MAP kinase activation
  • A. J. Whitmarsh, J. Cavanagh, C. Tournier, J. Yasuda, R. J. Davis, Science 1998, 281, 1671.
• 4)Scaffold proteins of MAP-kinase modules
  • D. N. Dhanasekaran, K. Kashef, C. M. Lee, H. Xu, E. P. Reddy, Oncogene 2007, 26, 3185.
• 5)Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
  • S.-H. Yang, A. J. Whitmarsh, R. J. Davis, A. D. Sharrocks, EMBO J. 1998, 17, 1740.